![Ivory Coast children are being given the latest malaria vaccine, known as R21/Matrix-M. (AP PHOTO) Ivory Coast children are being given the latest malaria vaccine, known as R21/Matrix-M. (AP PHOTO)](/images/transform/v1/crop/frm/silverstone-feed-data/fbc8ecc1-d2a8-46b0-bad4-3309b5d89d3a.jpg/r0_0_800_600_w1200_h678_fmax.jpg)
Health workers in Ivory Coast have begun giving children the latest malaria vaccine, the beginning of a regional campaign that experts hope might curb the impact of one of Africa's top killers.
Subscribe now for unlimited access.
or signup to continue reading
The West African country became the first to start rolling out the newest shot targeting malaria in an effort that aims to cover about 250,000 children under two.
The three-dose vaccine known as R21/Matrix-M was developed by Britain's Oxford University and was authorised by the World Health Organisation in October 2023.
Research suggests it is more than 75 per cent effective at preventing severe disease and death in the first year and that protection is extended for at least another year with a booster.
Alice Kanga was one of many who brought their children to get vaccinated on Monday.
"It's really important for the children, for their health," she said.
In 2021, WHO endorsed the first malaria vaccine, known as Mosquirix, made by GSK.
But that vaccine requires four doses and protection fades within months.
GSK also previously said it would only be able to make about 15 million doses.
But India's Serum Institute has already made 25 million doses of the Oxford vaccine and says it plans to make at least 100 million every year, at a cost of about $US4 ($A6) a dose.
More than 94 per cent of the world's roughly 249 million malaria cases and 608,000 deaths every year are in Africa.
The parasitic disease is spread by mosquitoes and most often strikes children under five and pregnant women.
Pierre Demba, Ivory Coast's health minister, said the malaria vaccination launch was an indication of the government's commitment to invest in the country's children.
"They are the future of our country," he said.
Adrian Hill of Oxford University said the Ivory Coast rollout "marks the start of a new era in malaria control", adding he hoped the shot would soon be available to all countries in Africa who wanted to use it.
Still, because malaria vaccines do not stop the spread of the disease, experts have long warned that other measures such as insecticide spraying, improved treatments and the use of bed nets will still be critical.
The Gavi vaccine alliance, which helps poor countries buy vaccines, said other countries including the Central African Republic, Chad and South Sudan have also received supplies of the Oxford-developed shot.
Australian Associated Press